Source: Picante Today

Prometheus Biosciences: PROMETHEUS BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX

NEW ORLEANS-(BUSINESS WIRE)-Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Prometheus Biosciences, Inc. (NasdaqGS: RXDX) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Prometheus will receive $200.00 in...

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Mark C. McKenna's photo - President & CEO of Prometheus Biosciences

President & CEO

Mark C. McKenna

CEO Approval Rating

90/100

Read more